HCmed Innovations Co., Ltd. (TPE:6934)

Market Cap	2.41B +22.1%
Revenue (ttm)	95.64M -29.2%
Net Income	-132.08M
EPS	-3.97
Shares Out	35.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,912
Open	67.20
Previous Close	67.20
Day's Range	66.30 - 67.20
52-Week Range	49.00 - 175.00
Beta	1.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About HCmed Innovations

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6934

Financial Performance

In 2025, HCmed Innovations's revenue was 100.23 million, a decrease of -29.22% compared to the previous year's 141.61 million. Losses were -126.11 million, 61.2% more than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 25, 2026

Data Sources Report a data error